Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Willingness-to-pay for the attributes of HPV vaccine

From: Parents’ preferences and willingness-to-pay for human papilloma virus vaccines in Thailand

Attributes Average Willingness-to-pay (95 % confidence interval) (Baht)
Fathers Mothers All
Constant (reference: no vaccination) 4,284.7 (−427.5 to 8,935.1) 7,831.4 (3,312.4 to 12,533.54) 6,240.4 (3,013.6 to 9,501.3)
Cervical cancer (1 in 1,000 risk reduction) 3,038.0 (2,234.7 to 4,076.0) 2,621.5 (2,366.3 to 3,207.0) 2,671.5 (2,142.0 to 3,297.8)
Genital warts (1 in 1,000 risk reduction) 103.6 (73.9 to 141.4) 135.2 (102.2 to 179.0) 119.0 (96.2 to 146.5)
Common side effect (1 in 100) −789.8 (−1,098.6 to −538.5) −708.9 (−987.6 to −478.4) −746.7 (− 949.0 to −571.7)